Keler Tibor
- SEC CIK
- 0001429931
No open-market purchases or sales filed in the past year.
Current role at each company
- CLDX Celldex Therapeutics, Inc.EXECUTIVE VP & CSOas of Jun 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Keler Tibor as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2022 (view filing) | Dec 7 | 2 days | Keler TiborEXECUTIVE VP & CSO | SSaleCommon Stock, par value $0.001 per share | −16.9K | $36.93 | −$622.6K | −69.6%7.36K after |